Dolby Laboratories (NYSE:DLB) SVP John Couling Sells 7,667 Shares of Stock

Dolby Laboratories (NYSE:DLBGet Free Report) SVP John Couling sold 7,667 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $53.20, for a total transaction of $407,884.40. Following the sale, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $6,316,276.40. This represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Dolby Laboratories Stock Down 2.2%

Dolby Laboratories stock traded down $1.12 during mid-day trading on Monday, hitting $50.03. The company’s stock had a trading volume of 1,305,232 shares, compared to its average volume of 802,703. The stock has a market capitalization of $4.73 billion, a P/E ratio of 19.77 and a beta of 0.81. Dolby Laboratories has a twelve month low of $50.03 and a twelve month high of $77.00. The stock’s fifty day moving average price is $55.29 and its two-hundred day moving average price is $60.61.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. The company had revenue of $395.63 million during the quarter, compared to the consensus estimate of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities analysts expect that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.9%. Dolby Laboratories’s dividend payout ratio (DPR) is 56.92%.

Analyst Ratings Changes

DLB has been the topic of several recent analyst reports. Rosenblatt Securities restated a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a report on Thursday, June 11th. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research report on Monday, June 15th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

View Our Latest Stock Analysis on Dolby Laboratories

Institutional Investors Weigh In On Dolby Laboratories

Institutional investors have recently bought and sold shares of the business. Fifth Third Bancorp grew its stake in Dolby Laboratories by 34.7% during the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in shares of Dolby Laboratories during the third quarter worth approximately $56,000. iSAM Funds UK Ltd acquired a new stake in shares of Dolby Laboratories during the third quarter worth approximately $68,000. Hilltop National Bank purchased a new position in Dolby Laboratories during the fourth quarter valued at approximately $69,000. Finally, Allworth Financial LP increased its stake in Dolby Laboratories by 99.6% in the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after buying an additional 502 shares during the period. 58.56% of the stock is currently owned by institutional investors and hedge funds.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.